Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital

Table 1

Clinicopathological characteristics and treatment options of laryngeal carcinosarcoma.

Sex	Age (years)	Tumor sites	Stage	Treatment	Follow-up
M	65	glottis	T1N0M0	laser + Rad 66 Gy	DFS, 47 months
M	59	glottis	T2N0M0	laser +Rad 80 Gy	DFS, 22 months
M	45	supraglottis	T2N0M0	First: laser; Second: PL+WND+Rad 66 Gy	DFS, 94 months
F	62	glottis	T3N0M0	PL+RND+Rad 66 Gy	DFS, 58 months
M	56	glottis	T3N0M0	TL+WND+Rad 66 Gy	DFS, 11 months
M	35	glottis	T3N2M0	First: PL+LND+Rad 70 Gy; Second: RND	DFS, 37 months
F	58	supraglottis	T3N2M0	TL+WND+Rad 70 Gy	DFS, 23 months
M	60	glottis	T1N0M0	laser	DFS, 58month
M	69	glottis	T2N0M0	First: laser; Second: TL+RND	DFS, 14 months
M	78	glottis	T2N0M0	laser	Died, 13 months
M	32	glottis	T2N0M0	laser +WND	Died, 12 months
M	43	glottis	T3N1M0	TL+WND	Died, 5 months
M	58	glottis	T3N2M0	TL+RND	Died, 11 months

Laser: CO2 laser surgery; Rad: radiotherapy; PL: partial laryngectomy; TL: total laryngectomy; LND: left neck dissection; RND: right neck dissection; WND: whole neck dissection; DFS: disease-free survival.